NuGEN Technology is a provider of genomics sample preparation solutions enabling scientists to access true biology in all samples.
NuGEN is a provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount for analysis on leading analytical platforms. Committed to advancing the life sciences, NuGEN ensures robust and reproducible results for researchers seeking to predict disease risk and drug response, potentially shortening the path to treatment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 10, 2007 | Debt Financing | $3M | 1 | Hercules Capital | — | Detail |
Aug 20, 2003 | Series C | $7.50M | 1 | — | — | Detail |
Dec 3, 2001 | Series B | $10.80M | 2 | — | — | Detail |
Nov 1, 2000 | Series A | $2M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hercules Capital | Yes | Debt Financing |
MedCapital | — | Series C |
Tenex Medical Investors | — | Series B |